Clinical trial

Premixed Glucagon/Insulin Solution for Faster Insulin Absorption in Type 1 Diabetes

NCT06854861

StatusSUSPENDED

Study typeINTERVENTIONAL

Start date2025-04-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2025-04-01Date precision: day

Registry last updated2025-06-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

Lyumjev 100 UNT/ML Injectable SolutionDRUG · verified · RxNorm: insulin lispro-aabc 100 UNT/ML Injectable Solution [Lyumjev]

Premixed LyumjevDRUG

Sponsors & collaborators

St. Olavs Hospitallead sponsor

Norwegian University of Science and Technologycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06854861 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.